Biote Corp.

NASDAQ: BTMD
Share price (3/28/25): $3.39
Market cap (3/28/25): $185 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/24 FY 2024

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

Prospectuses and Registrations Filter

Prospectus supplement

Prospectus supplement

Prospectus supplement

Prospectus supplement

Prospectus supplement

Ownership Filter

Christensen Bret

Cone Stephen Mark

Roystone Capital Management LP

News Filter

Investor Presentation

Reports Fourth Quarter and Full Year 2024 Financial Results Strengthened Business With Launch of BioteRx and Enhancements to Biote Method Provides Fiscal 2025 Outlook

Announces CEO Retirement and Succession Plan Terry Weber Retiring as CEO and Director and Transitioning to Strategic Advisor to Company’s Board of Directors

Reports Third Quarter 2024 Financial Results Continued Profitable Growth Vertical Integration Drives Gross Profit Margin Improvement Launch of Proprietary Clinical Decision Support Software to Strengthen Competitive Advantages

Reports Second Quarter 2024 Financial Results Procedure Revenue Growth Accelerates Sequentially BioteRx Roll-Out on Track With Further Expansion Planned Management Reiterates 2024 Financial Guidance

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Definitive proxy

Additional info about upcoming vote

Additional info about upcoming vote

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Notice of effectiveness

Letter from the SEC

Correspondence with the SEC